Bidirectional interactions between bone metabolism and hematopoiesis

Experimental Hematology

Volumn 39, Issue 8, 2011, Pages 809-816

  Despars, Geneviève ^a   St Pierre, Yves ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; PADGEM PROTEIN; THROMBOPOIETIN;

B LYMPHOCYTE; BONE CELL; BONE DEFECT; BONE MARROW CELL; BONE METABOLISM; CELL ADHESION; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; ERYTHROCYTE; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; MACROPHAGE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MESENCHYME; MESENCHYME CELL; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 79960621736     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2011.04.008     Document Type: Review

References (89)

1. Calvi L.M., Adams G.B., Weibrecht K.W., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
2. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841.
3. Zhu J., Garrett R., Jung Y., et al. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 2007, 109:3706-3712.
4. Lord B.I., Testa N.G., Hendr J.H. The relative spatial distribution of CFUs and CFUc in the normal mouse femur. Blood 1975, 46:65-72.
5. Gong J.K. Endosteal marrow: a rich source of hematopoietic stem cells. Science 1978, 199:1443-1445.
6. Haylock D.N., Williams B., Johnston H.M., et al. Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum. Stem Cells 2007, 25:1062-1069.
7. Winkler I.G., Barbier V., Wadley R., Zannettino A.C.W., Williams S., Lévesque J.-P. Positioning of bone marrow hematopoietic and stromal cells relative to blood flow in vivo: serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches. Blood 2010, 116:375-385.
8. Shi S., Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 2003, 18:696-704.
9. Dennis J.E., Charbord P. Origin and differentiation of human and murine stroma. Stem Cells 2002, 20:205-214.
10. Olmsted-Davis E., Gannon F.H., Ozen M., et al. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol 2007, 170:620-632.
11. Fouletier Dilling C., Wada A.M., Lazard Z.W., et al. Vessel formation is induced prior to the appearance of cartilage in BMP-2-mediated heteropic ossification. J Bone Miner Res 2010, 25:1147-1156.
12. Morrison S.J., Shah N.M., Anderson D.J. Regulatory mechanisms in stem cell biology. Cell 1997, 88:287-298.
13. Schofield R. The relationship between the spleen colony-forming cell and the hematopoietic stem cell. Blood Cells 1978, 4:7-25.
14. Zon L.I. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature 2008, 453:306-313.
15. Iwasaki H., Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity 2007, 26:726-740.
16. Geddis A.E. Megakaryopoiesis. Semin Hematol 2010, 47:212-219.
17. Dale D.C., Boxer L., Liles W.C. The phagocytes: neutrophils and monocytes. Blood 2008, 112:935-945.
18. Teitelbaum S.L., Ross F.P. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003, 4:638-649.
19. Muruganandan S., Roman A.A., Sinal C.J. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci 2009, 66:236-253.
20. Pacifici R. T cells: critical bone regulators in health and disease. Bone 2010, 47:461-471.
21. Horowitz M.C., Fretz J.A., Lorenzo J.A. How B cells influence bone biology in health and disease. Bone 2010, 47:472-479.
22. Visnjic D., Kalajzic I., Gronowicz G., et al. Conditional ablation of the osteoblast lineage in Col2.3Δtk transgenic mice. J Bone Miner Res 2001, 16:2222-2231.
23. Visnjic D., Kalajzic Z., Rowe D.W., Katavic V., Lorenzo J., Aguila H.L. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 2004, 103:3258-3264.
24. Yoshida H., Hayashi S.-I., Kunisada T., et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990, 345:442-444.
25. Kong Y.-Y., Yoshida H., Sarosi I., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397:315-323.
26. 3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol Rev 2005, 208:88-105.
27. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007, 7:292-304.
28. Kiel M.J., Morrison S.J. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 2008, 290:290-301.
29. Arai F., Hirao A., Ohmura M., et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004, 118:149-161.
30. Kiel M.J., Yilmaz ÖH., Iwashita T., Yilmaz O.H. Terhorst, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
31. Heissig B., Hattori K., Dias S., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand. Cell 2002, 109:625-637.
32. Butler J.M., Nolan D.J., Vertes E., et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 2010, 6:251-264.
33. Eto T., Winkler I., Purton L.E., Lévesque J.P. Contrasting effects of P-selectin and E-selectin on the differentiation of murine hematopoietic progenitor cells. Exp Hematol 2005, 33:232-242.
34. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003, 9:653-660.
35. Doherty M.J., Ashton B.A., Walsh S., Beresford J.N., Grant M.E., Canfield A.E. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 1998, 13:828-838.
36. Kalajzic I., Kalajzic Z., Wang L., et al. Pericyte/myofibroblast phenotype of osteoprogenitor cell. J Musculoskelet Neuronal Interact 2007, 7:320-322.
37. Kalajzic Z., Li H., Wang L.P., et al. Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population. Bone 2008, 43:501-510.
38. Sacchetti B., Funari A., Michienzi S., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
39. Méndez-Ferrer S., Michurina T.V., Ferraro F., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
40. Yoshihara H., Arai F., Hosokawa K., et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 2007, 1:685-697.
41. Nilsson S.K., Johnston H.M., Whitty G.A., et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005, 106:1232-1239.
42. Stier S., Ko Y., Forkert R., et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulated stem cell pool size. J Exp Med 2005, 201:1781-1791.
43. Grassinger J., Haylock D.N., Storan M.J., et al. Thrombin-cleaved osteopontin regulates hemopoetic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. Blood 2009, 114:49-59.
44. Kiel M.J., Radice G.L., Morrison S.J. Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem Cell 2007, 1:204-207.
45. Haug J.S., He X.C., Grindley J.C., et al. N-cadherin expression level distingues reserved versus primed states of hematopoietic stem cells. Cell Stem Cell 2008, 2:367-379.
46. Kiel M.J., Acar M., Radice G.L., Morrison S.J. Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance. Cell Stem Cell 2009, 4:170-179.
47. Hosokawa K., Arai F., Yoshihara H., et al. Knockdown of N-cadherin suppresses the long-term engraftment of hematopoietic stem cells. Blood 2010, 116:554-563.
48. Jung Y., Wang J., Havens A., et al. Cell-to-cell contact is critical for the survival of hematopoietic progenitor cells on osteoblasts. Cytokine 2005, 32:155-162.
49. Winkler I.G., Sims N.A., Pettit A.R., et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSC. Blood 2010, 116:4815-4828.
50. Lymperi S., Ersek A., Ferraro F., Dazzi F., Horwood N.J. Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood 2011, 117:1540-1549.
51. Kollet O., Dar A., Shivtiel S., et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 2006, 12:657-664.
52. Kacena M.A., Shivdasani R.A., Wilson K., et al. Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2. J Bone Miner Res 2004, 19:652-660.
53. Lemieux J.M., Horowitz M.C., Kacena M.A. Involvement of integrins α3β1 and α5β1 and glycoprotein IIb in megakaryocyte-induced osteoblast proliferation. J Cell Biochem 2010, 109:927-932.
54. Rafii S., Shapiro F., Pettengell R., et al. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 1995, 86:3353-3363.
55. Avecilla S.T., Hattori K., Heissig B., et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004, 10:64-71.
56. Beeton C.A., Bord S., Ireland D., Compston J.E. Osteoclast formation and bone resorption are inhibited by megakaryocytes. Bone 2006, 39:985-990.
57. Kacena M.A., Nelson T., Clough M.E., et al. Megakaryocyte-mediated inhibition of osteoclast development. Bone 2006, 39:991-999.
58. Durand C., Dzierzak E. Embryonic beginnings of adult hematopoietic stem cells. Haematologica 2005, 90:100-108.
59. Chagraoui J., Lepage-Noll A., Anjo A., Uzan G., Charbord P. Fetal liver stroma consists of cells in epithelial-to-mesenchymal transition. Blood 2003, 101:2973-2982.
60. Aguila H.L., Rowe D.W. Skeletal development, bone remodeling, and hematopoiesis. Immunol Rev 2005, 208:7-18.
61. Adams G.B., Chabner K.T., Alley I.R., et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 2006, 439:599-603.
62. Cackowski F.C., Anderson J.L., Patrene K.D., et al. Osteoclasts are important for bone angiogenesis. Blood 2010, 115:140-149.
63. Fuller K, Ross JL, Szewczyk KA, Moss R, Chambers TJ. Bone is not essential for osteoclast activation. PloS One. 5(9):e12837.doi:. doi:10.1371/journal.pone.0012837.
64. Bellahcène A., Bonjean K., Fohr B., et al. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 2000, 86:885-891.
65. Nimer S.D. Myelodysplastic syndromes. Blood 2008, 111:4841-4851.
66. Tefferi A. The history of myeloproliferative disorders: before and after Dameshek. Leukemia 2008, 22:3-13.
67. Diamond R., Smith A., Schnier R., Manoharan A. Syndrome of myelofibrosis and osteosclerosis: a series of case reports and review of the literature. Bone 2002, 30:498-501.
68. Mellibovsky L., Diez A., Serrano S., et al. Bone remodeling alterations in myelodysplastic syndrome. Bone 1996, 19:401-405.
69. Raaijmakers M.H.G.P., Mukherjee S., Gui S., et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukemia. Nature 2010, 464:852-857.
70. Varrichio L., Mancini A., Migliaccio A.R. Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis. Expert Rev Hematol 2009, 2:315-334.
71. Vyas P., Ault K., Jackson C.W., Orkin S.H., Shivdasani R.A. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 1999, 93:2867-2875.
72. Shivdasani R.A., Fujiwara Y., McDevitt M.A., Orkin S.H. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 1997, 16:3965-3973.
73. Shivdasani R.A., Rosenblatt M.F., Zucker-Franklin D., et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 1995, 81:695-704.
74. Kacena M.A., Gundberg C.M., Nelson T., Horowitz M.C. Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype. Bone 2005, 36:215-223.
75. Vannuchi A.L., Bianchi L., Cellai C., et al. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1 low mice). Blood 2002, 100:1123-1132.
76. Chan A.S., Jensen K.K., Skokos D., et al. Id1 represses osteoclast-dependent transcription and affects bone formation and hematopoiesis. PLoS ONE 2009, 4(11):e7955.
77. Suh H.C., Ji M., Gooya J., Lee M., Klarmann K.D., Keller J.R. Cell-nonautonomous function of Id1 in the hematopoietic progenitor cell niche. Blood 2009, 114:1186-1195.
78. Walkley C.R., Shea J.M., Sims N.A., Purton L.E., Orkin S.H. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 2007, 129:1081-1095.
79. min mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS. Blood 2010, 115:3489-3497.
80. Xu C., Wang S., Yu W.-M., et al. A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells. Blood 2010, 116:3611-3621.
81. Lazner F., Gowen M., Pavasovic D., Kola I. Osteopetrosis and osteoporosis: two sides of the same coin. Hum Mol Genet 1999, 8:1839-1846.
82. Helfrich M.H. Osteoclast diseases. Microsc Res Tech 2003, 61:514-532.
83. Takeshita S., Namba N., Zhao J.J., et al. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat Med 2002, 8:943-949.
84. Desponts C., Hazen A.L., Paraiso K.H.T., Kerr W.G. SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation. Blood 2006, 107:4338-4345.
85. Hazen A.L., Smith M.J., Desponts C., Winter O., Moser K., Kerr W.G. SHIP is required for a functional hematopoietic stem cell niche. Blood 2009, 113:2924-2933.
86. Chan C.K.F., Chen C.-C., Luppen C.A., et al. Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 2009, 457:490-495.
87. Jung Y., Song J., Shiowaza Y., et al. Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem Cells 2008, 26:2042-2051.
88. Kaigler D., Krebsbach P.H., West E.R., Horger K., Huang Y.-C., Mooney D.J. Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J 2005, 19:665-667.
89. Li Y., Toraldo G., Li A., et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 2007, 109:3839-3848.